Action of Intravenously Administered Talipexole on the Rat Striatal Neurons Receiving Excitatory Input from Nigral Dopamine Neurons

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1995 Aug 1

PMID 8539316

Authors

H Matsubayashi

T Amano

Y Hongjing

Y Kohno

M Sasa

Affiliations

Soon will be listed here.

Abstract

Electrophysiological studies using rats anesthetized with chloral hydrate were performed to elucidate whether or not intravenously injected talipexole acted as a D2 receptor agonist on the striatal neurons in comparison with the action of bromocriptine. The activities of the striatal neurons were extracellularly recorded using a glass microelectrode attached along a seven-barreled micropipette, each barrel of which was filled with talipexole, bromocriptine, SCH23390 (D1 antagonist), domperidone (D2 antagonist), glutamate or 2 M NaCl. These drugs were iontophoretically applied to the immediate vicinity of the target neuron being recorded. The effects of talipexole and bromocriptine were examined on the neurons, whose spikes (induced by the stimulation of the substantia nigra pars compacta) were inhibited by the iontophoretic application of domperidone. Iontophoretic application of talipexole or bromocriptine increased spontaneous firing of these neurons and this increase in firing was also inhibited by iontophoretically applied domperidone. In the same neurons, intravenously administered talipexole (0.01, 0.02 and 0.04 mg/kg) dose-dependently increased firing, and this increase was inhibited by microiontophoretically applied domperidone, but not by SCH23390. On the other hand, the intravenous injection of bromocriptine (0.1, 0.2 and 0.4 mg/kg) also increased the firing rate. However, the increase was not dose-dependent and fluctuated; the firing transiently decreased during the increase in firing with intravenously administered bromocriptine. However, the bromocriptine-induced increase in firing was also suppressed by domperidone, and decrease in firing was inhibited by SCH23390. These findings suggest that talipexole acts as a D2 agonist on the striatal neurons receiving input from substantia nigra pars compacta and increases firing when intravenously applied.(ABSTRACT TRUNCATED AT 250 WORDS)

References

Yamada K, Nagashima M, Kimura H, Matsumoto S, Furukawa T . Possible involvement of differing classes of dopamine D-2 receptors in yawning and stereotypy in rats. Psychopharmacology (Berl). 1990; 100(2):141-4. DOI: 10.1007/BF02244396. View

Pettibone D, TOTARO J, Clineschmidt B . Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390. J Neural Transm. 1987; 69(1-2):147-51. DOI: 10.1007/BF01244105. View

Yamada K, Matsumoto S, Nagashima M, Shirakawa K, Furukawa T . Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat. J Neural Transm Gen Sect. 1990; 79(1-2):19-24. DOI: 10.1007/BF01250996. View

Schrell U, Fahlbusch R, Adams E, Nomikos P, Reif M . Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors. J Clin Endocrinol Metab. 1990; 71(6):1669-71. DOI: 10.1210/jcem-71-6-1669. View

Fujimoto S, Sasa M, Takaori S . Inhibition from locus coeruleus of caudate neurons activated by nigral stimulation. Brain Res Bull. 1981; 6(3):267-74. DOI: 10.1016/s0361-9230(81)80057-3. View

Kita T, Kita H, Kitai S . Passive electrical membrane properties of rat neostriatal neurons in an in vitro slice preparation. Brain Res. 1984; 300(1):129-39. DOI: 10.1016/0006-8993(84)91347-7. View

Todo N, Momiyama T, Amano T, Kohno Y, Sasa M . Excitation by talipexole, a dopamine D2 agonist, of caudate nucleus neurons activated by nigral stimulation. Life Sci. 1994; 54(14):957-66. DOI: 10.1016/0024-3205(94)00497-8. View

Hinzen D, Hornykiewicz O, KOBINGER W, Pichler L, Pifl C, Schingnitz G . The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. Eur J Pharmacol. 1986; 131(1):75-86. DOI: 10.1016/0014-2999(86)90517-0. View

Akaike A, Ohno Y, Sasa M, Takaori S . Excitatory and inhibitory effects of dopamine on neuronal activity of the caudate nucleus neurons in vitro. Brain Res. 1987; 418(2):262-72. DOI: 10.1016/0006-8993(87)90094-1. View

10.

Johansen P, Clarkl D, White F . B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence. Life Sci. 1988; 43(6):515-24. DOI: 10.1016/0024-3205(88)90153-1. View

11.

CLARKE P, Wyder K, JAKUBOVIC A, Fibiger H . Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats. Br J Pharmacol. 1990; 99(3):509-15. PMC: 1917341. DOI: 10.1111/j.1476-5381.1990.tb12959.x. View

12.

Ohno Y, Sasa M, Takaori S . Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate nucleus neurons activated by nigral stimulation. Life Sci. 1986; 38(20):1867-73. DOI: 10.1016/0024-3205(86)90142-6. View

13.

Bernardi G, Marciani M, Morocutti C, Pavone F, Stanzione P . The action of dopamine on rat caudate neurones intracellularly recorded. Neurosci Lett. 2009; 8(3):235-40. DOI: 10.1016/0304-3940(78)90128-3. View

14.

Ohno Y, Sasa M, Takaori S . Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons. Life Sci. 1987; 40(19):1937-45. DOI: 10.1016/0024-3205(87)90054-3. View

15.

Ohno Y, Sasa M, Takaori S . Dopamine D-2 receptor-mediated excitation of caudate nucleus neurons from the substantia nigra. Life Sci. 1985; 37(16):1515-21. DOI: 10.1016/0024-3205(85)90183-3. View

16.

Herrling P, Hull C . Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons. Brain Res. 1980; 192(2):441-62. DOI: 10.1016/0006-8993(80)90896-3. View

17.

Kitai S, Sugimori M, Kocsis J . Excitatory nature of dopamine in the nigro-caudate pathway. Exp Brain Res. 1976; 24(4):351-63. DOI: 10.1007/BF00235003. View

18.

Momiyama T, Sasa M, Takaori S . Inhibition by talipexole, a thiazolo-azepine derivative, of dopaminergic neurons in the ventral tegmental area. Life Sci. 1991; 49(7):535-43. DOI: 10.1016/0024-3205(91)90071-i. View